Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (28)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Tchirkov, A.
Right arrow Articles by Lansdorp, P. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tchirkov, A.
Right arrow Articles by Lansdorp, P. M.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Human Molecular Genetics, 2003, Vol. 12, No. 3 227-232
© 2003 Oxford University Press

Role of oxidative stress in telomere shortening in cultured fibroblasts from normal individuals and patients with ataxia–telangiectasia

Andrei Tchirkov1,{dagger} and Peter M. Lansdorp1,2,*

1The Terry Fox Laboratory, BC Cancer Agency, Vancouver, BC, Canada V5Z 1L3 and 2Department of Medicine, University of British Columbia, Vancouver, BC, Canada V5Z 4E3

Received August 21, 2002; Accepted November 26, 2002

Cells from patients with the autosomal recessive disorder ataxia–telangiectasia (A–T) display accelerated telomere shortening upon culture in vitro. It has been suggested that A–T cells are in a chronic state of oxidative stress, which could contribute to their enhanced telomere shortening. In order to examine this hypothesis, we monitored the changes in telomere length in A–T homozygous, heterozygous and control fibroblasts cultured in vitro under various conditions of oxidative stress using quantitative fluorescent in situ hybridization. Compared with normal cells, the rate of telomere shortening was 1.5-fold increased under ‘normal’ levels of oxidative stress in A–T heterozygous cells and 2.4–3.2-fold in A–T homozygous cells. Mild chronic oxidative stress induced by hydrogen peroxide increased the rate of telomere shortening in A–T cells but not in normal fibroblasts and the telomere shortening rate decreased in both normal and A–T fibroblasts if cultures were supplemented with the anti-oxidant phenyl-butyl-nitrone. Increased telomere shortening upon oxidative stress in A–T cells was associated with a significant increase in the number of extra-chromosomal fragments of telomeric DNA and chromosome ends without detectable telomere repeats. We propose that the ATM (A–T mutated) protein has a role in the prevention or repair of oxidative damage to telomeric DNA and that enhanced sensitivity of telomeric DNA to oxidative damage in A–T cells results in accelerated telomere shortening and chromosomal instability.

* To whom correspondence should be addressed at: Terry Fox Laboratory, BC Cancer Agency, 601 West 10th Avenue, Vancouver, BC, Canada V5Z 1L3. Tel: +1 6048776070, ext. 3026; Fax: +1 6048770712; E-mail: plansdor{at}bccancer.bc.ca

{dagger} Present address: Département de Radiothérapie, Centre Jean Perrin, Clermont-Ferrand 63011, France.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
MutagenesisHome page
J. A. Lemon, C. D. Rollo, and D. R. Boreham
Elevated DNA damage in a mouse model of oxidative stress: impacts of ionizing radiation and a protective dietary supplement
Mutagenesis, November 1, 2008; 23(6): 473 - 482.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
I. Spyridopoulos, Y. Erben, T. H. Brummendorf, J. Haendeler, K. Dietz, F. Seeger, C. K. Kissel, H. Martin, J. Hoffmann, B. Assmus, et al.
Telomere Gap Between Granulocytes and Lymphocytes Is a Determinant for Hematopoetic Progenitor Cell Impairment in Patients With Previous Myocardial Infarction
Arterioscler. Thromb. Vasc. Biol., May 1, 2008; 28(5): 968 - 974.
[Abstract] [Full Text] [PDF]


Home page
GeneticsHome page
J. L. Yanowitz
Genome Integrity Is Regulated by the Caenorhabditis elegans Rad51D Homolog rfs-1
Genetics, May 1, 2008; 179(1): 249 - 262.
[Abstract] [Full Text] [PDF]


Home page
Arch Intern MedHome page
L. F. Cherkas, J. L. Hunkin, B. S. Kato, J. B. Richards, J. P. Gardner, G. L. Surdulescu, M. Kimura, X. Lu, T. D. Spector, and A. Aviv
The Association Between Physical Activity in Leisure Time and Leukocyte Telomere Length
Arch Intern Med, January 28, 2008; 168(2): 154 - 158.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
M. Muftuoglu, H. K. Wong, S. Z. Imam, D. M. Wilson III, V. A. Bohr, and P. L. Opresko
Telomere Repeat Binding Factor 2 Interacts with Base Excision Repair Proteins and Stimulates DNA Synthesis by DNA Polymerase {beta}
Cancer Res., January 1, 2006; 66(1): 113 - 124.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
P. L. Opresko, J. Fan, S. Danzy, D. M. Wilson III, and V. A. Bohr
Oxidative damage in telomeric DNA disrupts recognition by TRF1 and TRF2
Nucleic Acids Res., February 24, 2005; 33(4): 1230 - 1239.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
I. Spyridopoulos, J. Haendeler, C. Urbich, T. H. Brummendorf, H. Oh, M. D. Schneider, A. M. Zeiher, and S. Dimmeler
Statins Enhance Migratory Capacity by Upregulation of the Telomere Repeat-Binding Factor TRF2 in Endothelial Progenitor Cells
Circulation, November 9, 2004; 110(19): 3136 - 3142.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
D. J. Kurz, S. Decary, Y. Hong, E. Trivier, A. Akhmedov, and J. D. Erusalimsky
Chronic oxidative stress compromises telomere integrity and accelerates the onset of senescence in human endothelial cells
J. Cell Sci., May 1, 2004; 117(11): 2417 - 2426.
[Abstract] [Full Text] [PDF]


Home page
Mol Cancer ResHome page
Y. Bai and J. P. Murnane
Telomere Instability in a Human Tumor Cell Line Expressing NBS1 With Mutations at Sites Phosphorylated by ATM
Mol. Cancer Res., December 1, 2003; 1(14): 1058 - 1069.
[Abstract] [Full Text] [PDF]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.